4.6 Review

Recent Development of Gold Nanoparticles as Contrast Agents for Cancer Diagnosis

Journal

CANCERS
Volume 13, Issue 8, Pages -

Publisher

MDPI
DOI: 10.3390/cancers13081825

Keywords

gold nanoparticles; contrast agents; cancer diagnosis; active targeting; theranositics

Categories

Ask authors/readers for more resources

The development of nanotechnology has revolutionized the diagnosis and therapy of diseases, with gold nanoparticles being extensively researched for their excellent performance in this field. Gold nanoparticles have multiple functions and high efficiency, making them ideal for both therapeutic delivery and imaging diagnostics in cancer therapies and other biomedical applications.
Simple Summary The development of nanotechnology has brought revolution to the diagnosis and therapy of diseases, with a high precision and efficacy. Because nanoparticles can integrate multifunctions together including imaging, targeting, and therapeutics, they are more efficient than the standalone diagnostic or therapeutic entities. Among which, gold nanoparticles are most extensively investigated due to their excellent biocompatibility, versatility and ease of functionalization. Excepting the using of gold nanoparticles as vehicles for therapeutics delivery, they are also good candidates as contrast agents for imaging diagnosis, from magnetic resonance imaging, CT and nuclear imaging, fluorescence imaging, photoacoustic imaging to X-ray fluorescence imaging. We summarize their recent applications in these imaging modalities and challenges for their clinical translation. The last decade has witnessed the booming of preclinical studies of gold nanoparticles (AuNPs) in biomedical applications, from therapeutics delivery, imaging diagnostics, to cancer therapies. The synthetic versatility, unique optical and electronic properties, and ease of functionalization make AuNPs an excellent platform for cancer theranostics. This review summarizes the development of AuNPs as contrast agents to image cancers. First, we briefly describe the AuNP synthesis, their physical characteristics, surface functionalization and related biomedical uses. Then we focus on the performances of AuNPs as contrast agents to diagnose cancers, from magnetic resonance imaging, CT and nuclear imaging, fluorescence imaging, photoacoustic imaging to X-ray fluorescence imaging. We compare these imaging modalities and highlight the roles of AuNPs as contrast agents in cancer diagnosis accordingly, and address the challenges for their clinical translation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer

Xinning Wang, Aditi Shirke, Ethan Walker, Rongcan Sun, Gopolakrishnan Ramamurthy, Jing Wang, Lingpeng Shan, Joey Mangadlao, Zhipeng Dong, Jing Li, Ziying Wang, Mark Schluchter, Dong Luo, Yu Wang, Shaun Stauffer, Susann Brady-Kalnay, Christopher Hoimes, Zhenghong Lee, James P. Basilion

Summary: Researchers have developed a new PSMA-targeting drug conjugate with potent and selective antitumor activity, showing potential to impact therapeutic management of lethal prostate cancers.

CANCERS (2021)

Article Oncology

Development of near-infrared imaging agents for detection of junction adhesion molecule-A protein

E. Walker, S. M. Turaga, X. Wang, R. Gopalakrishnan, S. Shukla, J. P. Basilion, J. D. Lathia

Summary: The study demonstrated the successful non-invasive detection and visualization of prostate and breast cancerous tissues in vivo using a novel JAM-A mAb/IR700 conjugate, showing therapeutic and prognostic potential while being able to image specific receptor expression without post-image processing.

TRANSLATIONAL ONCOLOGY (2021)

Review Oncology

Photodynamic Therapy: Targeting Cancer Biomarkers for the Treatment of Cancers

Xinning Wang, Dong Luo, James P. Basilion

Summary: Photodynamic therapy (PDT) is an effective treatment modality for cancers that uses harmless light to activate photosensitizers, targeting specific tumor cells to improve treatment efficacy and reduce toxicity to normal tissues. Recent advancements in targeted delivery of photosensitizers to cancer cells have shown promising results in enhancing PDT outcomes.

CANCERS (2021)

Article Endocrinology & Metabolism

Development of a novel castration-resistant orthotopic prostate cancer model in New Zealand White rabbit

Yu Wang, Eric C. Abenojar, Jing Wang, Al C. Leon, Sidhartha Tavri, Xinning Wang, Ramamurthy Gopalakrishnan, Ethan Walker, Gregory T. MacLennan, Anoja Giles, Gregory J. Czarnota, James P. Basilion, Agata A. Exner

Summary: In this study, a prostate cancer model was successfully established in immunosuppressed rabbits, providing a clinically relevant intermediate step for assessing preclinical interventions. The minimally invasive ultrasound-guided tumor cell injection proved to be a better method compared to laparotomy, allowing for shorter recovery time for the rabbits.

PROSTATE (2022)

Article Oncology

Formulation of a Thermosensitive Imaging Hydrogel for Topical Application and Rapid Visualization of Tumor Margins in the Surgical Cavity

Ethan Walker, Daan G. J. Linders, Eric Abenojar, Xinning Wang, Hans Marten Hazelbag, Marieke E. Straver, Okker D. Bijlstra, Taryn L. March, Alexander L. Vahrmeijer, Agata Exner, Matthew Bogyo, James P. Basilion, Brian Straight

Summary: A formulation of a fluorescent molecular probe has been developed to enhance the resection quality for solid-tumor cancers. This formulation can be topically applied immediately after surgery and activates in the presence of residual cancer, providing a strong fluorescent signal to precisely delineate any remaining cancer cells. The utilization of this formulation has the potential to reduce re-excisions and improve patient quality of life.

CANCERS (2022)

Article Endocrinology & Metabolism

Evaluation of a photodynamic therapy agent using a canine prostate cancer model

Dong Luo, Xinning Wang, Gopalakrishnan Ramamurthy, Ethan Walker, Lifang Zhang, Aditi Shirke, Naraen G. Naidu, Clemens Burda, Reena Shakya, Eric T. Hostnik, Mathew Joseph, Lee Ponsky, Vladimir Ponomarev, Thomas J. Rosol, Michael F. Tweedle, James P. Basilion

Summary: Researchers have developed a canine model for studying the effectiveness of PSMA-targeted gold nanoparticles in the imaging and therapy of early stage prostate cancer. The nanoparticles allowed visualization of cancer cells and their destruction when exposed to specific wavelength light.

PROSTATE (2023)

Article Chemistry, Multidisciplinary

Prostate-specific membrane antigen targeted gold nanoparticles for prostate cancer radiotherapy: does size matter for targeted particles?

Dong Luo, Xinning Wang, Sophia Zeng, Gopalakrishnan Ramamurthy, Clemens Burda, James P. Basilion

CHEMICAL SCIENCE (2019)

No Data Available